Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 457

Showing 26-50 of 457 citing articles:

Ferroptosis: a new hunter of hepatocellular carcinoma
Yulang Jiang, Yongxin Yu, Ziyang Pan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Versatile function of NF-ĸB in inflammation and cancer
Qiang Ma, Shuai Hao, Weilong Hong, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Hierarchically Micro-, Meso-, and Macro-Porous MOF Nanosystems for Localized Cross-Scale Dual-Biomolecule Loading and Guest-Carrier Cooperative Anticancer Therapy
Qiaomei Ke, Ke Jiang, Hong Li, et al.
ACS Nano (2024) Vol. 18, Iss. 33, pp. 21911-21924
Closed Access | Times Cited: 18
NADPH Oxidase‐Like Nanozyme for High‐Efficiency Tumor Therapy Through Increasing Glutathione Consumption and Blocking Glutathione Regeneration
Di Han, Binbin Ding, Pan Zheng, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 11
Closed Access | Times Cited: 15
Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy
Wei Xu, Guoqiang Guan, Renye Yue, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 4
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
Zhongsong Zhang, Rong Wang, Long Chen
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 483-503
Open Access | Times Cited: 3
Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
Haotian Qin, Juan Xu, Yaohang Yue, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
In defence of ferroptosis
Francesca M. Alves, Darius J.R. Lane, Triet Phu Minh Nguyen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Cell death: The underlying mechanisms of photodynamic therapy for skin diseases
H.Y. Li, Jingjie Shen, Chunfu Zheng, et al.
Deleted Journal (2025)
Open Access | Times Cited: 2
Ferroptosis: Promising approach for cancer and cancer immunotherapy
Shuyue Zheng, Xin‐Yuan Guan
Cancer Letters (2023) Vol. 561, pp. 216152-216152
Closed Access | Times Cited: 38
Current evidence and therapeutic implication of PANoptosis in cancer
Dickson Kofi Wiredu Ocansey, Fei Qian, Peipei Cai, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 640-661
Open Access | Times Cited: 33
Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance
Ya Liu, Haibo Lei, Wenyou Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 31
Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis
X R Wang, Xianghai Kong, Xin Feng, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3558-3575
Open Access | Times Cited: 27
Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
Xiangdong Liu, Bo Luo, Xinhong Wu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189013-189013
Closed Access | Times Cited: 27
Paraptosis: a non-classical paradigm of cell death for cancer therapy
Chuncao Xu, Yifan Lin, Mu-yang Huang, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 2, pp. 223-237
Closed Access | Times Cited: 26
TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11/xCT K11-linked ubiquitination and degradation
Zhangjie Wang, Na Shen, Ziao Wang, et al.
Cell Death and Differentiation (2023) Vol. 31, Iss. 1, pp. 53-64
Closed Access | Times Cited: 26
Novel targets for gastric cancer: The tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis and cuproptosis
Peizheng Yang, Wanting Yang, Wei Zhong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114883-114883
Open Access | Times Cited: 24
Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer
Fei Wu, Minglei Wang, Tao Zhong, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy
Deze Zhao, Yu Meng, Yating Dian, et al.
Redox Biology (2023) Vol. 68, pp. 102966-102966
Open Access | Times Cited: 23
Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance
Jaewang Lee, Jong‐Lyel Roh
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1218-1218
Open Access | Times Cited: 22
Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Jiahua Liu, Qihang Yuan, Hui Guo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116310-116310
Open Access | Times Cited: 14
Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 14
Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death
Elena V. Sazonova, Maria A. Yapryntseva, Nikolay V. Pervushin, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 388-388
Open Access | Times Cited: 13
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence
Shuman Zhen, Yunlong Jia, Yan Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13

Scroll to top